Move upstream. Control sleep therapy growth at the source
.png)
Millions of patients with sleep apnea remain undiagnosed.
By the time they reach a DME, referrals are inconsistent, documentation is fragmented, and therapy intent is unclear delaying setup and impacting throughput
Soliish inserts intelligence at the very beginning of the sleep journey,
ensuring higher-quality patients reach therapy faster.
Operational clarity. Predictable volume. Faster therapy starts.
.png){kind=icon}
Predictable Patient Flow
.png){kind=icon}
Higher Conversion Rates
.png){kind=icon}
Reduced Intake Bottlenecks
No therapy lock-in
The sleep therapy opportunity is growing
But access is the bottleneck
Sleep apnea remains undiagnosed
Never enter formal sleep pathways
Increases therapy engagement
Soliish identifies high-risk patients earlier and ensures they are referred with structured, complete documentation. This enables DMEs to receive patients who are better qualified and closer to therapy readiness.
A therapy-ready patient has clear risk identification, supporting clinical context, and a defined referral pathway - reducing delays in qualification, setup, and therapy initiation.
Soliish standardizes screening and documentation upstream, reducing fragmented referrals. This results in clearer therapy intent, fewer back-and-forths, and faster patient onboarding.
Yes. Soliish is designed to fit into existing referral and intake workflows without requiring major operational changes, enabling DMEs to scale without adding overhead.
By delivering structured patient data and consistent referral information, Soliish minimizes manual verification steps and reduces delays in patient processing and setup.
Yes. Soliish is therapy-agnostic and supports multiple treatment pathways, ensuring patients are directed to the most appropriate therapy without disrupting existing DME operations.
Patients identified and referred through Soliish have clearer clinical context and intent, which improves qualification rates and increases the likelihood of therapy initiation.
Soliish provides structured, standardized screening outputs based on objective craniofacial markers, supporting consistent and defensible patient qualification.
No. Soliish is a screening and risk identification tool. Diagnosis and therapy decisions remain with qualified medical providers.
DMEs typically see improvements in referral clarity, intake efficiency, and patient conversion as soon as structured referrals begin flowing into their system.
